Pharmaceutical & Medical Device

Our Pharmaceutical & Medical Device practice combines deep industry knowledge with broad litigation and regulatory capabilities and trial‑ready strength to manage the mass tort, class action, and product liability disputes that our clients in the sector face, from early strategy through trial and exit.

We are known for our deep bench of first-chair trial lawyers, whose trial readiness sends a strong signal to opposing counsel that cases should not be assumed to settle. Our trial teams regularly litigate and win in courtrooms across the country, including in some of the most challenging jurisdictions for defendants, and have the experience and resources to fight simultaneously on multiple fronts—a capability rare at any firm. 

Understanding that our clients must safeguard both their businesses and the market viability of their products, we deliver a truly integrated defense—pairing seasoned litigators with a first-class team of lawyer-scientists and regulatory specialists for a comprehensive, 360° strategy. As one client noted to Chambers USA, “Cases can spill over into other things like regulatory issues… King & Spalding can bring it all.” And we do.

Our clients benefit from our multi-disciplinary and science-based approach tailored to pharmaceutical and medical device matters:

  • We have a dedicated team focused on identifying, preparing, and defending medical and scientific expert witnesses – and strategically challenging plaintiffs’ experts, including achieving exclusions under Daubert. This team combines lawyer-scientists and specialists with advanced degrees in areas including epidemiology, toxicology, pharmacology, biochemistry, biostatistics and physiology, among others.
  • Our team includes lawyers and professionals with deep knowledge of relevant scientific and medical issues, including former Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), and Department of Justice (DOJ) officials.
  • With the proven ability to staff and litigate large dockets in all stages of mass tort litigation, we have served as national coordinating, trial, and resolution counsel for pharmaceutical and medical device companies in dozens of multi-district litigation (MDLs) and state court consolidated proceedings involving tens of thousands of individual claims, helping clients minimize exposure with the highest level of defense.

Related Lawyers

TaCara Harris
Partner
Product Liability & Mass Torts
Andrew T. Bayman (Andy)
Partner
Product Liability & Mass Torts
Geoffrey M. Drake
Partner
Product Liability & Mass Torts
Eva Canaan
Partner
Product Liability & Mass Torts
Julia Zousmer
Partner
Product Liability & Mass Torts
Robert B. Friedman
Partner
Product Liability & Mass Torts
Russell Gaudreau III (Chip)
Partner
Product Liability & Mass Torts
Lana K. Varney
Partner
Product Liability & Mass Torts
Amanda J. Klingler
Partner
Government Matters & Regulation

Featured Insights

Featured Events

a blue and green background
Conference
September 15, 2026
Medical Device Summit 2026
a blue and green background
Webinar
July 21, 2026
Drug Advertising Midyear Review: An Update of 2026 FDA Enforcement and Key Developments

Latest News

Related Tags